Publication: Gene therapy for aromatic L-amino acid decarboxylase deficiency: Requirements for safe application and knowledge-generating follow-up
This original article, published in JIMD, explores the requirements and recommendations for patients who receive gene therapy for aromatic L-amino acid decarboxylase (AADC) deficiency
- Learn more about AADC deficiency, a rare genetic disorder
- Evaluate gene therapy as a treatment option for AADC deficiency
- Review the consensus recommendations for intraputaminal gene therapy preparation, delivery, and management, including postoperative care
MED-US-CORP-2500008 | November 2025
Roubertie A, et al. J Inherit Metab Dis. 2023. Epub ahead of print
Thank you!
Already registered?
Register now to access the content on this page
Already registered?
If not, register below
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
MED-US-CORP-2600001 | February 2026
COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.